Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Onkologie 2011; 34: 362-367.
- Keyword
-
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2013
- Contributor
-
Beckmann, Matthias W.
Brucker, Cosima
Hanf, Volker
Rauh, Claudia
Bani, Mayada R.
Knob, Stefanie
Petsch, Sabrina
Schick, Stefan
Fasching, Peter A.
Hartmann, Arndt
Lux, Michael P.
Häberle, Lothar
- URN
-
urn:nbn:de:bvb:29-opus-42966
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beckmann, Matthias W.
- Brucker, Cosima
- Hanf, Volker
- Rauh, Claudia
- Bani, Mayada R.
- Knob, Stefanie
- Petsch, Sabrina
- Schick, Stefan
- Fasching, Peter A.
- Hartmann, Arndt
- Lux, Michael P.
- Häberle, Lothar
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2013
Other Objects (12)
Invasive Breast Cancer: Recognition of Molecular Subtypes
Are Certified Breast Centers Cost-Effective?
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
Invasive Breast Cancer: Recognition of Molecular Subtypes
Are Certified Breast Centers Cost-Effective?
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
Invasive Breast Cancer: Recognition of Molecular Subtypes
Are Certified Breast Centers Cost-Effective?
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer